Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 112

Published Date: 13 Jan 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Contract Research Organization (CRO) and CDMO for Pharmaceutical market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Contract Research Organization (CRO) and CDMO for Pharmaceutical market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Contract Research Organization (CRO) and CDMO for Pharmaceutical market size and forecasts, in consumption value ($ Million), 2018-2029
Global Contract Research Organization (CRO) and CDMO for Pharmaceutical market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Contract Research Organization (CRO) and CDMO for Pharmaceutical market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Contract Research Organization (CRO) and CDMO for Pharmaceutical market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Contract Research Organization (CRO) and CDMO for Pharmaceutical
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Contract Research Organization (CRO) and CDMO for Pharmaceutical market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include IQVIA, ICON (Incl. PRA), Labcorp, Syneos Health and PPD (Thermo Fisher), etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Contract Research Organization (CRO) and CDMO for Pharmaceutical market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Preclinical CROs
    Clinical CROs

Market segment by Application
    Pharmaceutical & Biotechnological Companies
    Medical Device Companies
    Academic & Research Institutes
    Others

Market segment by players, this report covers
    IQVIA
    ICON (Incl. PRA)
    Labcorp
    Syneos Health
    PPD (Thermo Fisher)
    Medpace
    Parexel
    Wuxi Apptec
    Charles River
    Pharmaron
    EPS International
    Worldwide Clinical Trials
    CMIC
    Inotiv
    JOINN Lab
    ChemPartner
    Medicilon
    EVOTEC

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Contract Research Organization (CRO) and CDMO for Pharmaceutical product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Contract Research Organization (CRO) and CDMO for Pharmaceutical, with revenue, gross margin and global market share of Contract Research Organization (CRO) and CDMO for Pharmaceutical from 2018 to 2023.
Chapter 3, the Contract Research Organization (CRO) and CDMO for Pharmaceutical competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Contract Research Organization (CRO) and CDMO for Pharmaceutical market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Contract Research Organization (CRO) and CDMO for Pharmaceutical.
Chapter 13, to describe Contract Research Organization (CRO) and CDMO for Pharmaceutical research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Contract Research Organization (CRO) and CDMO for Pharmaceutical
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Contract Research Organization (CRO) and CDMO for Pharmaceutical by Type
        1.3.1 Overview: Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Market Share by Type in 2022
        1.3.3 Preclinical CROs
        1.3.4 Clinical CROs
    1.4 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market by Application
        1.4.1 Overview: Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Pharmaceutical & Biotechnological Companies
        1.4.3 Medical Device Companies
        1.4.4 Academic & Research Institutes
        1.4.5 Others
    1.5 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size & Forecast
    1.6 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast by Region
        1.6.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Region, (2018-2029)
        1.6.3 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Prospect (2018-2029)
        1.6.4 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Prospect (2018-2029)
        1.6.6 South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 IQVIA
        2.1.1 IQVIA Details
        2.1.2 IQVIA Major Business
        2.1.3 IQVIA Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
        2.1.4 IQVIA Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 IQVIA Recent Developments and Future Plans
    2.2 ICON (Incl. PRA)
        2.2.1 ICON (Incl. PRA) Details
        2.2.2 ICON (Incl. PRA) Major Business
        2.2.3 ICON (Incl. PRA) Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
        2.2.4 ICON (Incl. PRA) Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 ICON (Incl. PRA) Recent Developments and Future Plans
    2.3 Labcorp
        2.3.1 Labcorp Details
        2.3.2 Labcorp Major Business
        2.3.3 Labcorp Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
        2.3.4 Labcorp Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Labcorp Recent Developments and Future Plans
    2.4 Syneos Health
        2.4.1 Syneos Health Details
        2.4.2 Syneos Health Major Business
        2.4.3 Syneos Health Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
        2.4.4 Syneos Health Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Syneos Health Recent Developments and Future Plans
    2.5 PPD (Thermo Fisher)
        2.5.1 PPD (Thermo Fisher) Details
        2.5.2 PPD (Thermo Fisher) Major Business
        2.5.3 PPD (Thermo Fisher) Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
        2.5.4 PPD (Thermo Fisher) Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 PPD (Thermo Fisher) Recent Developments and Future Plans
    2.6 Medpace
        2.6.1 Medpace Details
        2.6.2 Medpace Major Business
        2.6.3 Medpace Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
        2.6.4 Medpace Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Medpace Recent Developments and Future Plans
    2.7 Parexel
        2.7.1 Parexel Details
        2.7.2 Parexel Major Business
        2.7.3 Parexel Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
        2.7.4 Parexel Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Parexel Recent Developments and Future Plans
    2.8 Wuxi Apptec
        2.8.1 Wuxi Apptec Details
        2.8.2 Wuxi Apptec Major Business
        2.8.3 Wuxi Apptec Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
        2.8.4 Wuxi Apptec Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Wuxi Apptec Recent Developments and Future Plans
    2.9 Charles River
        2.9.1 Charles River Details
        2.9.2 Charles River Major Business
        2.9.3 Charles River Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
        2.9.4 Charles River Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Charles River Recent Developments and Future Plans
    2.10 Pharmaron
        2.10.1 Pharmaron Details
        2.10.2 Pharmaron Major Business
        2.10.3 Pharmaron Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
        2.10.4 Pharmaron Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Pharmaron Recent Developments and Future Plans
    2.11 EPS International
        2.11.1 EPS International Details
        2.11.2 EPS International Major Business
        2.11.3 EPS International Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
        2.11.4 EPS International Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 EPS International Recent Developments and Future Plans
    2.12 Worldwide Clinical Trials
        2.12.1 Worldwide Clinical Trials Details
        2.12.2 Worldwide Clinical Trials Major Business
        2.12.3 Worldwide Clinical Trials Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
        2.12.4 Worldwide Clinical Trials Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Worldwide Clinical Trials Recent Developments and Future Plans
    2.13 CMIC
        2.13.1 CMIC Details
        2.13.2 CMIC Major Business
        2.13.3 CMIC Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
        2.13.4 CMIC Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 CMIC Recent Developments and Future Plans
    2.14 Inotiv
        2.14.1 Inotiv Details
        2.14.2 Inotiv Major Business
        2.14.3 Inotiv Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
        2.14.4 Inotiv Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Inotiv Recent Developments and Future Plans
    2.15 JOINN Lab
        2.15.1 JOINN Lab Details
        2.15.2 JOINN Lab Major Business
        2.15.3 JOINN Lab Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
        2.15.4 JOINN Lab Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 JOINN Lab Recent Developments and Future Plans
    2.16 ChemPartner
        2.16.1 ChemPartner Details
        2.16.2 ChemPartner Major Business
        2.16.3 ChemPartner Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
        2.16.4 ChemPartner Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        2.16.5 ChemPartner Recent Developments and Future Plans
    2.17 Medicilon
        2.17.1 Medicilon Details
        2.17.2 Medicilon Major Business
        2.17.3 Medicilon Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
        2.17.4 Medicilon Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        2.17.5 Medicilon Recent Developments and Future Plans
    2.18 EVOTEC
        2.18.1 EVOTEC Details
        2.18.2 EVOTEC Major Business
        2.18.3 EVOTEC Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
        2.18.4 EVOTEC Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        2.18.5 EVOTEC Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Contract Research Organization (CRO) and CDMO for Pharmaceutical by Company Revenue
        3.2.2 Top 3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Players Market Share in 2022
        3.2.3 Top 6 Contract Research Organization (CRO) and CDMO for Pharmaceutical Players Market Share in 2022
    3.3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market: Overall Company Footprint Analysis
        3.3.1 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market: Region Footprint
        3.3.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market: Company Product Type Footprint
        3.3.3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Market Share by Application (2018-2023)
    5.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Type (2018-2029)
    6.2 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Application (2018-2029)
    6.3 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Country
        6.3.1 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Country (2018-2029)
        6.3.2 United States Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2018-2029)
        6.3.3 Canada Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2018-2029)
        6.3.4 Mexico Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Type (2018-2029)
    7.2 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Application (2018-2029)
    7.3 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Country
        7.3.1 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Country (2018-2029)
        7.3.2 Germany Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2018-2029)
        7.3.3 France Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2018-2029)
        7.3.5 Russia Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2018-2029)
        7.3.6 Italy Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Region
        8.3.1 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Region (2018-2029)
        8.3.2 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2018-2029)
        8.3.3 Japan Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2018-2029)
        8.3.4 South Korea Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2018-2029)
        8.3.5 India Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2018-2029)
        8.3.7 Australia Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Type (2018-2029)
    9.2 South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Application (2018-2029)
    9.3 South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Country
        9.3.1 South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Country (2018-2029)
        9.3.2 Brazil Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2018-2029)
        9.3.3 Argentina Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Country
        10.3.1 Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Country (2018-2029)
        10.3.2 Turkey Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2018-2029)
        10.3.4 UAE Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Drivers
    11.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Restraints
    11.3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Contract Research Organization (CRO) and CDMO for Pharmaceutical Industry Chain
    12.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Upstream Analysis
    12.3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Midstream Analysis
    12.4 Contract Research Organization (CRO) and CDMO for Pharmaceutical Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. IQVIA Company Information, Head Office, and Major Competitors
    Table 6. IQVIA Major Business
    Table 7. IQVIA Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
    Table 8. IQVIA Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. IQVIA Recent Developments and Future Plans
    Table 10. ICON (Incl. PRA) Company Information, Head Office, and Major Competitors
    Table 11. ICON (Incl. PRA) Major Business
    Table 12. ICON (Incl. PRA) Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
    Table 13. ICON (Incl. PRA) Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. ICON (Incl. PRA) Recent Developments and Future Plans
    Table 15. Labcorp Company Information, Head Office, and Major Competitors
    Table 16. Labcorp Major Business
    Table 17. Labcorp Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
    Table 18. Labcorp Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Labcorp Recent Developments and Future Plans
    Table 20. Syneos Health Company Information, Head Office, and Major Competitors
    Table 21. Syneos Health Major Business
    Table 22. Syneos Health Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
    Table 23. Syneos Health Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Syneos Health Recent Developments and Future Plans
    Table 25. PPD (Thermo Fisher) Company Information, Head Office, and Major Competitors
    Table 26. PPD (Thermo Fisher) Major Business
    Table 27. PPD (Thermo Fisher) Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
    Table 28. PPD (Thermo Fisher) Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. PPD (Thermo Fisher) Recent Developments and Future Plans
    Table 30. Medpace Company Information, Head Office, and Major Competitors
    Table 31. Medpace Major Business
    Table 32. Medpace Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
    Table 33. Medpace Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Medpace Recent Developments and Future Plans
    Table 35. Parexel Company Information, Head Office, and Major Competitors
    Table 36. Parexel Major Business
    Table 37. Parexel Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
    Table 38. Parexel Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Parexel Recent Developments and Future Plans
    Table 40. Wuxi Apptec Company Information, Head Office, and Major Competitors
    Table 41. Wuxi Apptec Major Business
    Table 42. Wuxi Apptec Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
    Table 43. Wuxi Apptec Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Wuxi Apptec Recent Developments and Future Plans
    Table 45. Charles River Company Information, Head Office, and Major Competitors
    Table 46. Charles River Major Business
    Table 47. Charles River Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
    Table 48. Charles River Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Charles River Recent Developments and Future Plans
    Table 50. Pharmaron Company Information, Head Office, and Major Competitors
    Table 51. Pharmaron Major Business
    Table 52. Pharmaron Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
    Table 53. Pharmaron Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Pharmaron Recent Developments and Future Plans
    Table 55. EPS International Company Information, Head Office, and Major Competitors
    Table 56. EPS International Major Business
    Table 57. EPS International Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
    Table 58. EPS International Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. EPS International Recent Developments and Future Plans
    Table 60. Worldwide Clinical Trials Company Information, Head Office, and Major Competitors
    Table 61. Worldwide Clinical Trials Major Business
    Table 62. Worldwide Clinical Trials Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
    Table 63. Worldwide Clinical Trials Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. Worldwide Clinical Trials Recent Developments and Future Plans
    Table 65. CMIC Company Information, Head Office, and Major Competitors
    Table 66. CMIC Major Business
    Table 67. CMIC Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
    Table 68. CMIC Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. CMIC Recent Developments and Future Plans
    Table 70. Inotiv Company Information, Head Office, and Major Competitors
    Table 71. Inotiv Major Business
    Table 72. Inotiv Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
    Table 73. Inotiv Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 74. Inotiv Recent Developments and Future Plans
    Table 75. JOINN Lab Company Information, Head Office, and Major Competitors
    Table 76. JOINN Lab Major Business
    Table 77. JOINN Lab Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
    Table 78. JOINN Lab Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 79. JOINN Lab Recent Developments and Future Plans
    Table 80. ChemPartner Company Information, Head Office, and Major Competitors
    Table 81. ChemPartner Major Business
    Table 82. ChemPartner Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
    Table 83. ChemPartner Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 84. ChemPartner Recent Developments and Future Plans
    Table 85. Medicilon Company Information, Head Office, and Major Competitors
    Table 86. Medicilon Major Business
    Table 87. Medicilon Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
    Table 88. Medicilon Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Medicilon Recent Developments and Future Plans
    Table 90. EVOTEC Company Information, Head Office, and Major Competitors
    Table 91. EVOTEC Major Business
    Table 92. EVOTEC Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Solutions
    Table 93. EVOTEC Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 94. EVOTEC Recent Developments and Future Plans
    Table 95. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (USD Million) by Players (2018-2023)
    Table 96. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Share by Players (2018-2023)
    Table 97. Breakdown of Contract Research Organization (CRO) and CDMO for Pharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 98. Market Position of Players in Contract Research Organization (CRO) and CDMO for Pharmaceutical, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 99. Head Office of Key Contract Research Organization (CRO) and CDMO for Pharmaceutical Players
    Table 100. Contract Research Organization (CRO) and CDMO for Pharmaceutical Market: Company Product Type Footprint
    Table 101. Contract Research Organization (CRO) and CDMO for Pharmaceutical Market: Company Product Application Footprint
    Table 102. Contract Research Organization (CRO) and CDMO for Pharmaceutical New Market Entrants and Barriers to Market Entry
    Table 103. Contract Research Organization (CRO) and CDMO for Pharmaceutical Mergers, Acquisition, Agreements, and Collaborations
    Table 104. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (USD Million) by Type (2018-2023)
    Table 105. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Share by Type (2018-2023)
    Table 106. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Forecast by Type (2024-2029)
    Table 107. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Application (2018-2023)
    Table 108. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Forecast by Application (2024-2029)
    Table 109. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Type (2018-2023) & (USD Million)
    Table 110. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Type (2024-2029) & (USD Million)
    Table 111. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Application (2018-2023) & (USD Million)
    Table 112. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Application (2024-2029) & (USD Million)
    Table 113. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Country (2018-2023) & (USD Million)
    Table 114. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Country (2024-2029) & (USD Million)
    Table 115. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Type (2018-2023) & (USD Million)
    Table 116. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Type (2024-2029) & (USD Million)
    Table 117. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Application (2018-2023) & (USD Million)
    Table 118. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Application (2024-2029) & (USD Million)
    Table 119. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Country (2018-2023) & (USD Million)
    Table 120. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Country (2024-2029) & (USD Million)
    Table 121. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Type (2018-2023) & (USD Million)
    Table 122. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Type (2024-2029) & (USD Million)
    Table 123. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Application (2018-2023) & (USD Million)
    Table 124. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Application (2024-2029) & (USD Million)
    Table 125. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Region (2018-2023) & (USD Million)
    Table 126. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Region (2024-2029) & (USD Million)
    Table 127. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Type (2018-2023) & (USD Million)
    Table 128. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Type (2024-2029) & (USD Million)
    Table 129. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Application (2018-2023) & (USD Million)
    Table 130. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Application (2024-2029) & (USD Million)
    Table 131. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Country (2018-2023) & (USD Million)
    Table 132. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Country (2024-2029) & (USD Million)
    Table 133. Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Type (2018-2023) & (USD Million)
    Table 134. Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Type (2024-2029) & (USD Million)
    Table 135. Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Application (2018-2023) & (USD Million)
    Table 136. Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Application (2024-2029) & (USD Million)
    Table 137. Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Country (2018-2023) & (USD Million)
    Table 138. Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Country (2024-2029) & (USD Million)
    Table 139. Contract Research Organization (CRO) and CDMO for Pharmaceutical Raw Material
    Table 140. Key Suppliers of Contract Research Organization (CRO) and CDMO for Pharmaceutical Raw Materials
List of Figures
    Figure 1. Contract Research Organization (CRO) and CDMO for Pharmaceutical Picture
    Figure 2. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Market Share by Type in 2022
    Figure 4. Preclinical CROs
    Figure 5. Clinical CROs
    Figure 6. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 7. Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Market Share by Application in 2022
    Figure 8. Pharmaceutical & Biotechnological Companies Picture
    Figure 9. Medical Device Companies Picture
    Figure 10. Academic & Research Institutes Picture
    Figure 11. Others Picture
    Figure 12. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 13. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 14. Global Market Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 15. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Market Share by Region (2018-2029)
    Figure 16. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Market Share by Region in 2022
    Figure 17. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029) & (USD Million)
    Figure 18. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029) & (USD Million)
    Figure 19. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029) & (USD Million)
    Figure 20. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029) & (USD Million)
    Figure 21. Middle East and Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029) & (USD Million)
    Figure 22. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Share by Players in 2022
    Figure 23. Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 24. Global Top 3 Players Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Share in 2022
    Figure 25. Global Top 6 Players Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Share in 2022
    Figure 26. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Share by Type (2018-2023)
    Figure 27. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Share Forecast by Type (2024-2029)
    Figure 28. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Share by Application (2018-2023)
    Figure 29. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Share Forecast by Application (2024-2029)
    Figure 30. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Market Share by Type (2018-2029)
    Figure 31. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Market Share by Application (2018-2029)
    Figure 32. North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Market Share by Country (2018-2029)
    Figure 33. United States Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029) & (USD Million)
    Figure 34. Canada Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029) & (USD Million)
    Figure 35. Mexico Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029) & (USD Million)
    Figure 36. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Market Share by Type (2018-2029)
    Figure 37. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Market Share by Application (2018-2029)
    Figure 38. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Market Share by Country (2018-2029)
    Figure 39. Germany Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029) & (USD Million)
    Figure 40. France Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029) & (USD Million)
    Figure 41. United Kingdom Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029) & (USD Million)
    Figure 42. Russia Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029) & (USD Million)
    Figure 43. Italy Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029) & (USD Million)
    Figure 44. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Market Share by Type (2018-2029)
    Figure 45. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Market Share by Application (2018-2029)
    Figure 46. Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Market Share by Region (2018-2029)
    Figure 47. China Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029) & (USD Million)
    Figure 48. Japan Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029) & (USD Million)
    Figure 49. South Korea Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029) & (USD Million)
    Figure 50. India Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029) & (USD Million)
    Figure 51. Southeast Asia Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029) & (USD Million)
    Figure 52. Australia Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029) & (USD Million)
    Figure 53. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Market Share by Type (2018-2029)
    Figure 54. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Market Share by Application (2018-2029)
    Figure 55. South America Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Market Share by Country (2018-2029)
    Figure 56. Brazil Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029) & (USD Million)
    Figure 57. Argentina Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029) & (USD Million)
    Figure 58. Middle East and Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Market Share by Type (2018-2029)
    Figure 59. Middle East and Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Market Share by Application (2018-2029)
    Figure 60. Middle East and Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Market Share by Country (2018-2029)
    Figure 61. Turkey Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029) & (USD Million)
    Figure 62. Saudi Arabia Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029) & (USD Million)
    Figure 63. UAE Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029) & (USD Million)
    Figure 64. Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Drivers
    Figure 65. Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Restraints
    Figure 66. Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Trends
    Figure 67. Porters Five Forces Analysis
    Figure 68. Manufacturing Cost Structure Analysis of Contract Research Organization (CRO) and CDMO for Pharmaceutical in 2022
    Figure 69. Manufacturing Process Analysis of Contract Research Organization (CRO) and CDMO for Pharmaceutical
    Figure 70. Contract Research Organization (CRO) and CDMO for Pharmaceutical Industrial Chain
    Figure 71. Methodology
    Figure 72. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

IQVIA
ICON (Incl. PRA)
Labcorp
Syneos Health
PPD (Thermo Fisher)
Medpace
Parexel
Wuxi Apptec
Charles River
Pharmaron
EPS International
Worldwide Clinical Trials
CMIC
Inotiv
JOINN Lab
ChemPartner
Medicilon
EVOTEC

Related Reports

Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Supply, Demand and Key Producers, 2023-2029

Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Supply, Demand and Key Producers, 2023-2029

date 04 Feb 2023

date Medical Care

The global Contract Research Organization (CRO) and CDMO for Pharmaceutical market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 16 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Contract Research Organization (CRO) and CDMO for Pharmaceutical market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Contract Research Organization (CRO) and CDMO for Pharmaceutical

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>